Liren Hu

593 total citations
20 papers, 437 citations indexed

About

Liren Hu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Liren Hu has authored 20 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Liren Hu's work include Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Liren Hu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Liren Hu collaborates with scholars based in China, United Kingdom and Türkiye. Liren Hu's co-authors include Jiayuan Wu, Taiping He, Gaohua Zhang, Lei Zou, Haiqing Luo, Wenjun Cao, Manyu Chen, Na Yao, Liquan Chen and Zhan‐Hui Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Medicine.

In The Last Decade

Liren Hu

19 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liren Hu China 12 159 121 104 85 69 20 437
Geng Dong China 12 146 0.9× 142 1.2× 52 0.5× 65 0.8× 53 0.8× 20 487
Diána Mühl Hungary 14 92 0.6× 153 1.3× 28 0.3× 43 0.5× 51 0.7× 38 450
Sebastian Hörber Germany 12 137 0.9× 67 0.6× 34 0.3× 53 0.6× 41 0.6× 33 522
Chien‐Hui Wu Taiwan 11 132 0.8× 87 0.7× 47 0.5× 137 1.6× 143 2.1× 43 482
Helen J. Madsen United States 10 152 1.0× 58 0.5× 65 0.6× 25 0.3× 131 1.9× 33 395
Monica Goldklang United States 11 107 0.7× 41 0.3× 37 0.4× 31 0.4× 54 0.8× 30 477
Yanyan He China 10 117 0.7× 41 0.3× 41 0.4× 118 1.4× 69 1.0× 26 461
Jiayuan Chen China 14 87 0.5× 101 0.8× 47 0.5× 84 1.0× 70 1.0× 28 498
Takeshi Fujita Japan 12 97 0.6× 40 0.3× 30 0.3× 56 0.7× 74 1.1× 47 421

Countries citing papers authored by Liren Hu

Since Specialization
Citations

This map shows the geographic impact of Liren Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liren Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liren Hu more than expected).

Fields of papers citing papers by Liren Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liren Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liren Hu. The network helps show where Liren Hu may publish in the future.

Co-authorship network of co-authors of Liren Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Liren Hu. A scholar is included among the top collaborators of Liren Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liren Hu. Liren Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luo, Haiqing, Guihua Yi, Lingli Chen, et al.. (2024). Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort study. Scientific Reports. 14(1). 18839–18839. 2 indexed citations
3.
Yu, Jiangping, et al.. (2023). Predicting Centrifugal Pumps’ Complete Characteristics Using Machine Learning. Processes. 11(2). 524–524. 5 indexed citations
4.
Li, Shasha, Xueying Huang, Jie Liu, et al.. (2022). Trends in the Incidence and DALYs of Urolithiasis From 1990 to 2019: Results From the Global Burden of Disease Study 2019. Frontiers in Public Health. 10. 825541–825541. 28 indexed citations
5.
Wu, Jiayuan, Hairong He, Huan Ma, et al.. (2020). Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis. International Journal of Colorectal Disease. 35(5). 795–804. 17 indexed citations
6.
Wu, Jiayuan, Quan Zhou, Zhenyu Pan, et al.. (2020). Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma. Medicine. 99(4). e18974–e18974. 19 indexed citations
7.
8.
Chen, Liquan, Gaohua Zhang, Zhan‐Hui Zhang, et al.. (2018). Neutrophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss. Medicine. 97(38). e12492–e12492. 36 indexed citations
9.
Wu, Jiayuan, et al.. (2017). Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis. Oncotarget. 8(19). 32332–32344. 64 indexed citations
10.
11.
Wu, Jiayuan, et al.. (2016). Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies. OncoTargets and Therapy. Volume 9. 4277–4288. 45 indexed citations
12.
Wu, Jiayuan, et al.. (2015). Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis. PLoS ONE. 10(7). e0133057–e0133057. 116 indexed citations
13.
Luo, Haiqing, Yiming Shao, Na Yao, et al.. (2015). Association of heme oxygenase-1 polymorphisms with cancer risk: A systematic review and meta-analysis.. PubMed. 20(4). 1142–53. 8 indexed citations
14.
15.
Wu, Jiayuan, et al.. (2015). Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies.. PubMed. 8(2). 1944–55. 4 indexed citations
16.
Luo, Haiqing, et al.. (2014). Metastasis-associated protein 1 as a new prognostic marker for solid tumors: a meta-analysis of cohort studies. Tumor Biology. 35(6). 5823–5832. 15 indexed citations
17.
Luo, Haiqing, et al.. (2014). Association between 3801T>C Polymorphism of CYP1A1 and Idiopathic Male Infertility Risk: A Systematic Review and Meta-Analysis. PLoS ONE. 9(1). e86649–e86649. 14 indexed citations
18.
Liang, Qi‐Lian, Guoqiang Chen, Zhouyu Li, et al.. (2014). Tumor suppressor TSLC1 inhibits growth, proliferation, invasiveness and angiogenesis in nude mice xenografted tumor of Eca109 cells.. PubMed. 7(6). 1507–15. 3 indexed citations
19.
Hu, Liren, et al.. (2013). Poor Prognosis of Phosphatase of Regenerating Liver 3 Expression in Gastric Cancer: A Meta-Analysis. PLoS ONE. 8(10). e76927–e76927. 9 indexed citations
20.
Li, Huawen, et al.. (2012). Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis. Molecular Biology Reports. 39(12). 10273–10284. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geng Dong Breakdown of academic impact, for papers by Diána Mühl Breakdown of academic impact, for papers by Sebastian Hörber Breakdown of academic impact, for papers by Chien‐Hui Wu Breakdown of academic impact, for papers by Helen J. Madsen Breakdown of academic impact, for papers by Monica Goldklang Breakdown of academic impact, for papers by Yanyan He Breakdown of academic impact, for papers by Jiayuan Chen Breakdown of academic impact, for papers by Takeshi Fujita
Rankless by CCL
2026